Wai Yuen Tong Medicine Holdings Limited

SEHK:897 Stock Report

Market Cap: HK$223.9m

Wai Yuen Tong Medicine Holdings Balance Sheet Health

Financial Health criteria checks 6/6

Wai Yuen Tong Medicine Holdings has a total shareholder equity of HK$1.4B and total debt of HK$460.9M, which brings its debt-to-equity ratio to 33.3%. Its total assets and total liabilities are HK$2.1B and HK$709.7M respectively. Wai Yuen Tong Medicine Holdings's EBIT is HK$40.9M making its interest coverage ratio -5.5. It has cash and short-term investments of HK$191.9M.

Key information

33.3%

Debt to equity ratio

HK$460.95m

Debt

Interest coverage ratio-5.5x
CashHK$191.85m
EquityHK$1.39b
Total liabilitiesHK$709.65m
Total assetsHK$2.10b

Recent financial health updates

Recent updates

Wai Yuen Tong Medicine Holdings Limited's (HKG:897) Share Price Boosted 51% But Its Business Prospects Need A Lift Too

Jul 26
Wai Yuen Tong Medicine Holdings Limited's (HKG:897) Share Price Boosted 51% But Its Business Prospects Need A Lift Too

Investors Give Wai Yuen Tong Medicine Holdings Limited (HKG:897) Shares A 46% Hiding

Mar 11
Investors Give Wai Yuen Tong Medicine Holdings Limited (HKG:897) Shares A 46% Hiding

The Strong Earnings Posted By Wai Yuen Tong Medicine Holdings (HKG:897) Are A Good Indication Of The Strength Of The Business

Dec 28
The Strong Earnings Posted By Wai Yuen Tong Medicine Holdings (HKG:897) Are A Good Indication Of The Strength Of The Business

Is Wai Yuen Tong Medicine Holdings (HKG:897) A Risky Investment?

Jul 11
Is Wai Yuen Tong Medicine Holdings (HKG:897) A Risky Investment?

Wai Yuen Tong Medicine Holdings (HKG:897) Takes On Some Risk With Its Use Of Debt

Jul 05
Wai Yuen Tong Medicine Holdings (HKG:897) Takes On Some Risk With Its Use Of Debt

Is Wai Yuen Tong Medicine Holdings (HKG:897) A Risky Investment?

Mar 08
Is Wai Yuen Tong Medicine Holdings (HKG:897) A Risky Investment?

Increases to Wai Yuen Tong Medicine Holdings Limited's (HKG:897) CEO Compensation Might Cool off for now

Aug 18
Increases to Wai Yuen Tong Medicine Holdings Limited's (HKG:897) CEO Compensation Might Cool off for now

Health Check: How Prudently Does Wai Yuen Tong Medicine Holdings (HKG:897) Use Debt?

Mar 17
Health Check: How Prudently Does Wai Yuen Tong Medicine Holdings (HKG:897) Use Debt?

Wai Yuen Tong Medicine Holdings' (HKG:897) Shareholders Are Down 75% On Their Shares

Jan 22
Wai Yuen Tong Medicine Holdings' (HKG:897) Shareholders Are Down 75% On Their Shares

Health Check: How Prudently Does Wai Yuen Tong Medicine Holdings (HKG:897) Use Debt?

Dec 16
Health Check: How Prudently Does Wai Yuen Tong Medicine Holdings (HKG:897) Use Debt?

Financial Position Analysis

Short Term Liabilities: 897's short term assets (HK$830.2M) exceed its short term liabilities (HK$380.9M).

Long Term Liabilities: 897's short term assets (HK$830.2M) exceed its long term liabilities (HK$328.8M).


Debt to Equity History and Analysis

Debt Level: 897's net debt to equity ratio (19.4%) is considered satisfactory.

Reducing Debt: 897's debt to equity ratio has reduced from 34.8% to 33.3% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Whilst unprofitable 897 has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.

Forecast Cash Runway: 897 is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 40.8% per year.


Discover healthy companies